X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
electricity (302) 302
electric communication technique (222) 222
pictorial communication, e.g. television (154) 154
physics (96) 96
humans (89) 89
performing operations (83) 83
transporting (83) 83
transmission of digital information, e.g. telegraphiccommunication (81) 81
basic electric elements (72) 72
information storage (67) 67
information storage based on relative movement between recordcarrier and transducer (67) 67
male (64) 64
female (62) 62
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (61) 61
index medicus (56) 56
aged (54) 54
mechanical metal-working without essentially removingmaterial (54) 54
punching metal (54) 54
middle aged (53) 53
rolling of metal (52) 52
oncology (51) 51
chemistry (50) 50
metallurgy (50) 50
chemotherapy (42) 42
cancer (34) 34
adult (33) 33
calculating (30) 30
computing (30) 30
counting (30) 30
general tagging of cross-sectional technologies spanning over several sections of the ipc (27) 27
general tagging of new technological developments (27) 27
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (27) 27
transmission (27) 27
electric digital data processing (26) 26
medicine & public health (25) 25
basic electronic circuitry (24) 24
general devices for heat treatment of ferrous or non-ferrousmetals or alloys (23) 23
making metal malleable by decarburisation, tempering or othertreatments (23) 23
metallurgy of iron (23) 23
metastasis (23) 23
modifying the physical structure of ferrous metals (23) 23
wireless communications networks (23) 23
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
analysis (19) 19
biochemistry & molecular biology (19) 19
japan (19) 19
treatment outcome (19) 19
gastroenterology & hepatology (18) 18
technical subjects covered by former uspc (18) 18
trial (18) 18
fluorouracil - administration & dosage (17) 17
patients (17) 17
aged, 80 and over (16) 16
esophageal cancer (16) 16
surgery (16) 16
surgical oncology (16) 16
tumors (16) 16
care and treatment (15) 15
multiplex communication (15) 15
animals (14) 14
cisplatin (14) 14
colorectal cancer (14) 14
diagnosis (14) 14
research (14) 14
biophysics (13) 13
fluorouracil (13) 13
gastroenterology (13) 13
stomach cancer (13) 13
stomach neoplasms - drug therapy (13) 13
technical subjects covered by former us classification (13) 13
therapy (13) 13
alloys (12) 12
antineoplastic agents - therapeutic use (12) 12
cancer research (12) 12
deoxycytidine - analogs & derivatives (12) 12
ferrous or non-ferrous alloys (12) 12
treatment of alloys or non-ferrous metals (12) 12
adenocarcinoma (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
apparatus therefor (11) 11
cancer therapies (11) 11
clinical trials (11) 11
code conversion in general (11) 11
coding (11) 11
decoding (11) 11
electrolytic or electrophoretic processes (11) 11
gastric cancer (11) 11
original (11) 11
5-fluorouracil (10) 10
capacitors (10) 10
cladding or plating by soldering or welding (10) 10
colorectal neoplasms - drug therapy (10) 10
cutting by applying heat locally, e.g. flame cutting (10) 10
machine tools (10) 10
metal-working not otherwise provided for (10) 10
molecular sequence data (10) 10
neoplasm staging (10) 10
radiotherapy (10) 10
retrospective studies (10) 10
soldering or unsoldering (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastric Cancer, ISSN 1436-3291, 7/2012, Volume 15, Issue 3, pp. 313 - 322
The Trastuzumab for Gastric Cancer (ToGA) study is the first international trial to include Japanese patients with human epidermal growth factor 2 (HER2)... 
Pathology | Medicine & Public Health | Gastroenterology | Oncology | Radiotherapy | Drug therapy | Surgical Oncology | Randomized controlled trial | Trastuzumab | Stomach neoplasms | CAPECITABINE | THERAPY | CISPLATIN | ONCOLOGY | PHASE-III | GASTROENTEROLOGY & HEPATOLOGY | CHEMOTHERAPY | Prognosis | Receptor, ErbB-2 - genetics | Capecitabine | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Stomach Neoplasms - metabolism | Male | Cisplatin - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Esophageal Neoplasms - metabolism | Aged, 80 and over | Esophageal Neoplasms - mortality | Adult | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Proportional Hazards Models | Survival Rate | Stomach Neoplasms - drug therapy | Asian Continental Ancestry Group | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Esophageal Neoplasms - drug therapy | Stomach Neoplasms - mortality | Deoxycytidine - analogs & derivatives | Medical colleges | Oncology, Experimental | College teachers | Metastasis | Research | Stomach cancer | Biometry | Chemotherapy | Epidermal growth factor | Analysis | Cross infection | Diabetes | Kidney diseases | Nosocomial infections | Public health | Cancer | Fluorouracil | Original
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 631 - 639
Journal Article
Journal of Thoracic Disease, ISSN 2072-1439, 06/2018, Volume 10, Issue Suppl 17, pp. S2086 - S2088
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4438 - 4444
Journal Article
Molecular and clinical oncology, ISSN 2049-9450, 05/2015, Volume 3, Issue 3, p. 539
Peritoneal metastasis (PM) in gastric cancer (GC) is often the cause of several complications, including ascites and bowel obstruction. The prognosis of... 
Journal Article
Cancer Science, ISSN 1347-9032, 04/2015, Volume 106, Issue 4, pp. 397 - 406
This study aimed to evaluate the feasibility of and immune response to Wilms tumor gene 1 (WT1) peptide‐pulsed dendritic cell vaccination combined with... 
first‐line therapy | neutrophil lymphocyte ratio | dendritic cell vaccination | Delayed‐type hypersensitivity | immunotherapy | Neutrophil lymphocyte ratio | Delayed-type hypersensitivity | Dendritic cell vaccination | First-line therapy | Immunotherapy | first-line therapy | BILIARY-TRACT CANCER | DUCTAL ADENOCARCINOMA | COMBINATION | TRIAL | THERAPY | ONCOLOGY | WT1 | SUPPRESSOR-CELLS | RESISTANT PROSTATE-CANCER | CARCINOMA | Dendritic Cells - immunology | Humans | Middle Aged | Vaccination | Male | Cancer Vaccines - therapeutic use | Deoxycytidine - therapeutic use | WT1 Proteins - pharmacology | C-Reactive Protein - metabolism | WT1 Proteins - immunology | Adult | Female | Pancreatic Neoplasms - mortality | Interleukin-8 - blood | Liver Neoplasms - secondary | Immunotherapy, Adoptive - adverse effects | Immunotherapy, Adoptive - methods | Neutrophils - immunology | Treatment Outcome | Combined Modality Therapy | Cancer Vaccines - immunology | Antimetabolites, Antineoplastic - therapeutic use | Pilot Projects | Pancreatic Neoplasms - immunology | Lymphocyte Count | Aged | CD8-Positive T-Lymphocytes - immunology | Dendritic Cells - transplantation | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Gemcitabine | Peptides | Hypersensitivity (delayed) | Genes | Liver | Clinical trials | Metastasis | Suppressor cells | Cancer therapies | Metastases | Liver cancer | Consent | Peripheral blood | Growth factors | Antigens | Dendritic cells | Inflammation | FDA approval | Disease control | Patients | Studies | Chemotherapy | Pancreatic cancer | Medical prognosis | Response rates | Interferon | Histocompatibility antigen HLA | Prostate cancer | Skin tests | Tumors | Original
Journal Article
Journal Article
Journal Article
Journal Article
The FEBS Journal, ISSN 1742-464X, 03/2018, Volume 285, Issue 6, pp. 1146 - 1161
Journal Article
Gastric Cancer, ISSN 1436-3291, 7/2016, Volume 19, Issue 3, pp. 902 - 910
Journal Article